Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 157

Results For "LAC"

1654 News Found

India should focus on pharma intermediates self-sufficiency : A column by Dr. K. Nagaiah,Chief Scientist & Head - Centre for Natural Product and Traditional Knowledge, CSIR-IICT, Hyderabad
interviews | August 17, 2021

India should focus on pharma intermediates self-sufficiency : A column by Dr. K. Nagaiah,Chief Scientist & Head - Centre for Natural Product and Traditional Knowledge, CSIR-IICT, Hyderabad

India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers


Indian pharma’s vaccine opportunity at US $ 10-11 billion
Biotech | August 17, 2021

Indian pharma’s vaccine opportunity at US $ 10-11 billion

Domestic market and developing countries will need doses of Indian vaccines


Glenmark Pharmaceuticals net profit at Rs 306.52 crores in Q1FY22
News | August 16, 2021

Glenmark Pharmaceuticals net profit at Rs 306.52 crores in Q1FY22

The company reports revenue growth of 26% and PAT growth of 21% YoY


Apollo Hospitals PAT at Rs 489.28 cr. in Q1FY22
Healthcare | August 16, 2021

Apollo Hospitals PAT at Rs 489.28 cr. in Q1FY22

The hospital chain aggressively embarks on digitisation and is e-health ready


India restricts export of Rapid Antigen Test Kits used to detect Covid 19
Policy | August 16, 2021

India restricts export of Rapid Antigen Test Kits used to detect Covid 19

The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT


Novatek Pharma initiates Phase II study of oral COVID-19 drug
Drug Approval | August 14, 2021

Novatek Pharma initiates Phase II study of oral COVID-19 drug

This therapy may provide the first potential oral treatment for COVID-19, recognizing the global emergency of new SARS-CoV-2 variants


USFDA grants distinct indication for Chronic Sleep Disorder
Drug Approval | August 13, 2021

USFDA grants distinct indication for Chronic Sleep Disorder

Idiopathic hypersomnia is a life-long condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder


Labcorp, a leader in women’s heath solutions acquires Ovia Health
Digitisation | August 13, 2021

Labcorp, a leader in women’s heath solutions acquires Ovia Health

The transaction improves patient experience, patient outcomes and aims to reduce health care costs


QIAGEN and GT Molecular collaborate to detect SARS-CoV-2 in wastewater
Drug Approval | August 11, 2021

QIAGEN and GT Molecular collaborate to detect SARS-CoV-2 in wastewater

Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases


GW Pharmaceuticals receives approval for Epidyolex to treat seizures
Drug Approval | August 11, 2021

GW Pharmaceuticals receives approval for Epidyolex to treat seizures

TSC causes epilepsy in up to 85 % of patients, and up to 60 % of those patients do not respond to standard anti-seizure medicines